Back to discover

Protein / target

1,4-alpha-glucan-branching enzyme

Encoded byGBE1Q04446Homo sapiensSwiss-Prot
Small-molecule tractable
Druggability
Structure with Ligand
1
Research papers

Protein at a glance

Biological role

Hydrolase activity, hydrolyzing O-glycosyl compounds

Strongest disease association

Glycogen Storage Disease

Via encoding gene GBE1 · Genetic evidence · score 0.93

Research activity

Emerging research

1 papers · latest 2024

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Glycogen-branching enzyme participates in the glycogen biosynthetic process along with glycogenin and glycogen synthase.

View complete UniProt function annotation

Glycogen-branching enzyme participates in the glycogen biosynthetic process along with glycogenin and glycogen synthase. Generates alpha-1,6-glucosidic branches from alpha-1,4-linked glucose chains, to increase solubility of the glycogen polymer (PubMed:26199317, PubMed:8463281, PubMed:8613547)

Domains and Gene Ontology detail (11)

Gene Ontology

  • Ccytoplasm
  • Ccytosol
  • Cextracellular exosome
  • F1,4-alpha-glucan branching enzyme activity
  • Fcarbohydrate binding
  • Fcation binding
  • Fhydrolase activity, hydrolyzing O-glycosyl compounds
  • Pgeneration of precursor metabolites and energy
  • Pglycogen biosynthetic process
  • Pglycogen metabolic process
  • Pnegative regulation of neuron apoptotic process

702 aa · 80 kDa

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene GBE1

Gene-level evidence surfaced through the gene GBE1that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Glycogen storage disease due to glycogen branching enzyme deficiency
0.95Well supported

Genetic evidence dominant · Open Targets 0.85

Glycogen Storage Disease
0.94Well supported

Genetic evidence dominant · Open Targets 0.57

Genetic Diseases, Inborn
0.84Well supported

Genetic evidence dominant · Open Targets 0.51

View evidence synthesis (3)
Glycogen storage disease due to glycogen branching enzyme deficiencyWell supported
0.95
agreement 0.841.00
Genetic69%Pathway18%Animal model9%Literature4%Genetic literaturedup

Open Targets aggregate 0.85 · 4 independent evidence families · 1 not counted as duplicate

Glycogen Storage DiseaseWell supported
0.94
agreement 0.801.00
Genetic98%Literature3%

Open Targets aggregate 0.57 · 2 independent evidence families

Genetic Diseases, InbornWell supported
0.84
agreement 0.700.98
Genetic99%Literature1%

Open Targets aggregate 0.51 · 2 independent evidence families

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Glycogen storage disease due to glycogen branching enzyme deficiency0.85
Glycogen Storage Disease0.57
Genetic Diseases, Inborn0.51

Tractability

Small moleculesEmerging

Feasibility evidence (structure with ligand) — no clinical-stage drug of this modality recorded.

Protein degradersEmerging

Feasibility evidence (database ubiquitination and half-life data) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (3)
SM · Structure with LigandPR · Database UbiquitinationPR · Half-life Data

Raw Open Targets tractability assessment buckets, by modality.

Research activity

1 papers · to 2024

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Badoni S · Proceedings of the National Academy of Sciences of the United States of America · 2024

Recent

Multiomics of a rice population identifies genes and genomic regions that bestow low glycemic index and high protein content.

Badoni S · Proceedings of the National Academy of Sciences of the United States of America · 2024

Europe PMC papers linked directly to this protein.